Arkolith/Insider Trading/ORTX/Form 4

Thomas Frank E

See RemarksOrchard Therapeutics plc (ORTX) · full profile →Form 4 · filed Apr 4, 2022
Net Buying
Open-Market Buys
$8K
Open-Market Sells
$0
Net Open-Market Flow
$8K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2022Buy(P)10K$0.75$8K52K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-022336) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML